Davita Inc (NYSE:DVA) was the target of unusually large options trading activity on Wednesday. Stock investors bought 1,169 call options on the stock. This represents an increase of 925% compared to the average daily volume of 114 call options.
Several analysts have commented on DVA shares. Bank of America upgraded shares of Davita from a “neutral” rating to a “buy” rating and raised their price objective for the stock from $75.00 to $85.00 in a report on Thursday, January 4th. Zacks Investment Research upgraded shares of Davita from a “hold” rating to a “buy” rating and set a $82.00 price objective for the company in a report on Tuesday, February 6th. Robert W. Baird restated a “buy” rating and issued a $95.00 price objective (up from $82.00) on shares of Davita in a report on Friday, January 12th. TheStreet upgraded shares of Davita from a “c” rating to a “b-” rating in a report on Thursday, January 4th. Finally, SunTrust Banks restated a “hold” rating and issued a $80.00 price objective on shares of Davita in a report on Wednesday, February 14th. Two analysts have rated the stock with a sell rating, five have given a hold rating, four have issued a buy rating and two have given a strong buy rating to the company’s stock. Davita presently has a consensus rating of “Hold” and an average target price of $79.30.
Several hedge funds and other institutional investors have recently made changes to their positions in DVA. OppenheimerFunds Inc. increased its stake in shares of Davita by 5,292.6% during the fourth quarter. OppenheimerFunds Inc. now owns 1,873,918 shares of the company’s stock valued at $135,391,000 after purchasing an additional 1,839,168 shares in the last quarter. Millennium Management LLC increased its stake in shares of Davita by 239.9% during the fourth quarter. Millennium Management LLC now owns 2,024,308 shares of the company’s stock valued at $146,256,000 after purchasing an additional 1,428,810 shares in the last quarter. Bridger Management LLC bought a new position in shares of Davita during the fourth quarter valued at approximately $52,339,000. International Value Advisers LLC bought a new position in shares of Davita during the fourth quarter valued at approximately $45,175,000. Finally, Locust Wood Capital Advisers LLC bought a new position in shares of Davita during the fourth quarter valued at approximately $20,657,000. 85.77% of the stock is owned by institutional investors and hedge funds.
Davita (NYSE:DVA) last announced its earnings results on Tuesday, February 13th. The company reported $0.92 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.94 by ($0.02). Davita had a net margin of 4.65% and a return on equity of 12.86%. The business had revenue of $2.78 billion for the quarter, compared to the consensus estimate of $3.90 billion. During the same period in the prior year, the business posted $0.98 EPS. sell-side analysts anticipate that Davita will post 4.16 EPS for the current year.
WARNING: “Davita Target of Unusually Large Options Trading (DVA)” was reported by StockNewsTimes and is owned by of StockNewsTimes. If you are reading this piece of content on another site, it was copied illegally and republished in violation of US & international trademark & copyright law. The correct version of this piece of content can be viewed at https://stocknewstimes.com/2018/04/26/davita-target-of-unusually-large-options-trading-dva.html.
Davita Company Profile
DaVita Inc, formerly DaVita HealthCare Partners Inc, operates two divisions: DaVita Kidney Care (Kidney Care) and DaVita Medical Group (DMG). The Kidney Care division consists of its the United States dialysis and related lab services, its ancillary services and strategic initiatives, including its international operations, and its corporate administrative support.
Receive News & Ratings for Davita Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Davita and related companies with MarketBeat.com's FREE daily email newsletter.